Cayman Chemical is a biotechnology firm that provides assay kits, antibodies, proteins, biochemicals, and contract services.
Cayman Chemical Company helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 25, 2019 | Grant | $1.50M | 2 | National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Yes | Grant |